Your browser doesn't support javascript.
loading
Allogeneic haematopoietic stem cell transplantation with decitabine-containing preconditioning regimen in TP53-mutant myelodysplastic syndromes: A case study.
Wang, Yuxin; Sun, Yao; Xie, Jing; Hu, Jiangwei; Liu, Na; Chen, Jianlin; Li, Botao; Lan, Sanchun; Niu, Jingwen; Wang, Lei; Qiao, Zhuoqing; Zhang, Yu; Ren, Jing; Zhang, Bin; Qian, Liren; Tan, Yehui; Dou, Liping; Li, Yuhang; Hu, Liangding.
Afiliación
  • Wang Y; Senior Department of Hematology, The Fifth Medical Centre of Chinese People's Liberation Army General Hospital, Beijing, China.
  • Sun Y; Senior Department of Hematology, The Fifth Medical Centre of Chinese People's Liberation Army General Hospital, Beijing, China.
  • Xie J; Senior Department of Hematology, The Fifth Medical Centre of Chinese People's Liberation Army General Hospital, Beijing, China.
  • Hu J; Senior Department of Hematology, The Fifth Medical Centre of Chinese People's Liberation Army General Hospital, Beijing, China.
  • Liu N; Senior Department of Hematology, The Fifth Medical Centre of Chinese People's Liberation Army General Hospital, Beijing, China.
  • Chen J; Senior Department of Hematology, The Fifth Medical Centre of Chinese People's Liberation Army General Hospital, Beijing, China.
  • Li B; Senior Department of Hematology, The Fifth Medical Centre of Chinese People's Liberation Army General Hospital, Beijing, China.
  • Lan S; Senior Department of Hematology, The Fifth Medical Centre of Chinese People's Liberation Army General Hospital, Beijing, China.
  • Niu J; Senior Department of Hematology, The Fifth Medical Centre of Chinese People's Liberation Army General Hospital, Beijing, China.
  • Wang L; Senior Department of Hematology, The Fifth Medical Centre of Chinese People's Liberation Army General Hospital, Beijing, China.
  • Qiao Z; Senior Department of Hematology, The Fifth Medical Centre of Chinese People's Liberation Army General Hospital, Beijing, China.
  • Zhang Y; Senior Department of Hematology, The Fifth Medical Centre of Chinese People's Liberation Army General Hospital, Beijing, China.
  • Ren J; Senior Department of Hematology, The Fifth Medical Centre of Chinese People's Liberation Army General Hospital, Beijing, China.
  • Zhang B; Senior Department of Hematology, The Fifth Medical Centre of Chinese People's Liberation Army General Hospital, Beijing, China.
  • Qian L; Senior Department of Hematology, The Fifth Medical Centre of Chinese People's Liberation Army General Hospital, Beijing, China.
  • Tan Y; Department of Hematology, The First Hospital of Jilin University, Changchun, China.
  • Dou L; Department of Hematology, Chinese People's Liberation Army General Hospital, Beijing, China.
  • Li Y; Senior Department of Hematology, The Fifth Medical Centre of Chinese People's Liberation Army General Hospital, Beijing, China.
  • Hu L; Senior Department of Hematology, The Fifth Medical Centre of Chinese People's Liberation Army General Hospital, Beijing, China.
Front Oncol ; 12: 928324, 2022.
Article en En | MEDLINE | ID: mdl-35924157
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China